US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kyverna Therapeutics

6.62

-0.1800-2.65%

Volume:230.93K

Turnover:1.55M

Market Cap:409.40M

PE:-2.30

High:6.91

Open:6.80

Low:6.61

Close:6.80

52wk High:13.67

52wk Low:5.30

Shares:61.84M

Float Shares:39.72M

Volume Ratio:0.58

T/O Rate:0.58%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8809

EPS(LYR):-3.6445

ROE:-87.24%

ROA:-44.51%

PB:2.47

PE(LYR):-1.82

Loading ...

Overview Company News Filings

US Stocks on the MOVE-Charles River, Oracle, TD Synnex

Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Kyverna Rises as Cell Therapy Shows Durable Benefit in Rare Nerve Disease

Swarmer’s miv-cel shows positive results in stiff person syndrome and gMG

Kyverna Reports Positive 1-Year KYSA-8 Trial Data for Miv-Cel in Stiff Person Syndrome

Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-Cel in Stiff Person Syndrome and Generalized Myasthenia Gravis

THOMSON REUTERS

Kyverna Therapeutics, - Phase 3 Kysa-6 Trial Enrollment Expected to be Completed in Mid-2027

THOMSON REUTERS

Kyverna Therapeutics, - Miv-Cel Well-Tolerated in Gmg Trial with no High-Grade Crs, Icans, or Iec-Hs

THOMSON REUTERS

Kyverna Therapeutics to Present at Wells Fargo Healthcare Conference Fireside Chat

Kyverna Therapeutics: Buy Rating Reiterated as Pipeline Progress and Strong Financial Runway Support Unchanged $25 Price Target

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF), Kyverna Therapeutics, Inc. (KYTX) and Pliant Therapeutics (PLRX)

Kyverna Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Kyverna Therapeutics Q2 EPS $(0.63) Beats $(0.68) Estimate

Benzinga Earnings

Kyverna Therapeutics reports Q2 EPS (63c), consensus (68c)

Kyverna Therapeutics Rilis Presentasi Investor Soal Terapi CAR-T Miv-Cel Untuk Penyakit Autoimun Neurologis

Kyverna Therapeutics Rugi Bersih Q2 FY26 Menyempit Jadi USD 38,32 Juta

Kyverna Therapeutics - on Track to Complete Rolling Bla Submission for Miv-Cel in SPS in Q4 2026

THOMSON REUTERS

Kyverna Therapeutics - Kysa-8 12-Month Topline Data Expected in Q3 2026

THOMSON REUTERS

Press Release: Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/KYTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYTX\",,,,,undefined,":{"symbol":"KYTX","market":"US","secType":"STK","nameCN":"Kyverna Therapeutics","latestPrice":6.62,"timestamp":1790867727095,"preClose":6.8,"halted":0,"volume":230927,"delay":0,"changeRate":-0.026470588235294076,"floatShares":39715000,"shares":61843444,"eps":-2.880877,"marketStatus":"Trading","change":-0.18,"latestTime":"10-01 11:15:31 EDT","open":6.8,"high":6.91,"low":6.61,"amount":1552676.2493089999,"amplitude":0.044118,"askPrice":6.63,"askSize":500,"bidPrice":6.61,"bidSize":12,"shortable":3,"etf":0,"ttmEps":-2.880877,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"listingDate":1707368400000,"exchange":"NASDAQ","adjPreClose":6.8,"preHourTrading":{"tag":"盘前","latestPrice":6.8,"preClose":6.8,"latestTime":"09:26 EDT","volume":14814,"amount":100733.97043799999,"timestamp":1790861172245,"change":0,"changeRate":0,"amplitude":0.004412},"postHourTrading":{"tag":"盘后","latestPrice":6.9231,"preClose":6.8,"latestTime":"19:53 EDT","volume":32351,"amount":220236.475,"timestamp":1790812412489,"change":0.1231,"changeRate":0.018103,"amplitude":0.021044},"volumeRatio":0.577731,"impliedVol":1.0773,"impliedVolPercentile":0.3267},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYTX\",,,,,undefined,":{"symbol":"KYTX","floatShares":39715000,"roa":"-44.51%","roe":"-87.24%","lyrEps":-3.644532,"volumeRatio":0.577731,"shares":61843444,"dividePrice":0,"high":6.91,"amplitude":0.044118,"preClose":6.8,"low":6.61,"week52Low":5.3,"pbRate":"2.47","psRate":"1451.79","week52High":13.67,"institutionHeld":0,"latestPrice":6.62,"committee":-0.953125,"eps":-2.880877,"divideRate":0,"volume":230927,"delay":0,"ttmEps":-2.880877,"open":6.8,"prevYearClose":9.4,"prevWeekClose":6.81,"prevMonthClose":6.8,"prevQuarterClose":6.8,"fiveDayClose":6.99,"twentyDayClose":8.615,"sixtyDayClose":9.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"KYTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-12","symbol":"KYTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2026-03-26","symbol":"KYTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.8,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2025-11-12","symbol":"KYTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.97,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2025-08-12","symbol":"KYTX","fiscalQuarterEnding":"2025/06","expectedEps":1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.97}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1755748800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYTX","date":"2026-09-29","current":-2.360392,"percent":0.543939,"low":-26.836094,"twenty":-4.179991,"median":-2.8765,"eighty":-1.131424,"high":-0.615209,"avg":-4.28126,"sd":5.585046,"marketCap":421772288},"quantilePoints":[{"date":"2024-02-09","current":-25.410847,"twenty":-24.055602,"median":-22.022734,"eighty":-19.989866,"marketCap":1224675750},{"date":"2024-02-16","current":-26.541682,"twenty":-26.641604,"median":-26.505996,"eighty":-25.427787,"marketCap":1279176368},{"date":"2024-02-23","current":-24.230994,"twenty":-26.541682,"median":-25.495549,"eighty":-24.578936,"marketCap":1167812779},{"date":"2024-03-01","current":-24.239916,"twenty":-26.505996,"median":-25.105309,"eighty":-24.54325,"marketCap":1168242754},{"date":"2024-03-08","current":-25.676289,"twenty":-26.318643,"median":-25.069622,"eighty":-24.578936,"marketCap":1237468769},{"date":"2024-03-15","current":-26.354329,"twenty":-26.354329,"median":-25.311608,"eighty":-24.712759,"marketCap":1270146888},{"date":"2024-03-22","current":-23.999034,"twenty":-26.354329,"median":-25.16776,"eighty":-24.239916,"marketCap":1156633422},{"date":"2024-03-28","current":-17.2201,"twenty":-26.32578,"median":-25.042858,"eighty":-23.820602,"marketCap":1039508532},{"date":"2024-04-05","current":-15.927342,"twenty":-26.311505,"median":-24.815357,"eighty":-20.313915,"marketCap":961469941},{"date":"2024-04-12","current":-17.062969,"twenty":-25.959995,"median":-24.578936,"eighty":-17.608641,"marketCap":1030023179},{"date":"2024-04-19","current":-13.577524,"twenty":-25.715544,"median":-24.235455,"eighty":-16.573007,"marketCap":819620788},{"date":"2024-04-26","current":-11.384836,"twenty":-25.597779,"median":-23.86521,"eighty":-16.071617,"marketCap":687256989},{"date":"2024-05-03","current":-10.734886,"twenty":-25.51207,"median":-23.093494,"eighty":-15.443094,"marketCap":648022117},{"date":"2024-05-10","current":-10.427767,"twenty":-25.427787,"median":-18.634621,"eighty":-13.461819,"marketCap":629482562},{"date":"2024-05-17","current":-8.660987,"twenty":-25.252064,"median":-17.663681,"eighty":-11.317698,"marketCap":657507471},{"date":"2024-05-24","current":-7.059414,"twenty":-25.176682,"median":-17.2201,"eighty":-10.732029,"marketCap":535922482},{"date":"2024-05-31","current":-7.116207,"twenty":-25.108877,"median":-16.627288,"eighty":-10.256351,"marketCap":540234007},{"date":"2024-06-07","current":-7.456968,"twenty":-25.053564,"median":-16.309455,"eighty":-9.030538,"marketCap":566103153},{"date":"2024-06-14","current":-5.412407,"twenty":-25.026799,"median":-16.020192,"eighty":-8.479248,"marketCap":410888275},{"date":"2024-06-21","current":-4.390126,"twenty":-24.958995,"median":-15.870204,"eighty":-7.953341,"marketCap":333280836},{"date":"2024-06-28","current":-4.259502,"twenty":-24.826956,"median":-14.259614,"eighty":-7.613717,"marketCap":323364330},{"date":"2024-07-05","current":-3.978375,"twenty":-24.748445,"median":-13.641804,"eighty":-7.429707,"marketCap":302022284},{"date":"2024-07-12","current":-5.56007,"twenty":-24.685994,"median":-12.649024,"eighty":-7.150283,"marketCap":422098238},{"date":"2024-07-19","current":-5.685015,"twenty":-24.571799,"median":-11.216991,"eighty":-6.028046,"marketCap":431583592},{"date":"2024-07-26","current":-5.588466,"twenty":-24.482583,"median":-10.813451,"eighty":-5.596417,"marketCap":424254000},{"date":"2024-08-02","current":-4.117518,"twenty":-24.238132,"median":-10.584898,"eighty":-5.421494,"marketCap":312585519},{"date":"2024-08-09","current":-3.725644,"twenty":-24.184602,"median":-9.999228,"eighty":-5.056881,"marketCap":282836000},{"date":"2024-08-16","current":-3.830678,"twenty":-23.972269,"median":-9.395703,"eighty":-4.700218,"marketCap":290809782},{"date":"2024-08-23","current":-4.597951,"twenty":-23.820602,"median":-8.80297,"eighty":-4.562778,"marketCap":349058032},{"date":"2024-08-30","current":-4.56385,"twenty":-23.561877,"median":-8.433813,"eighty":-4.558634,"marketCap":346469221},{"date":"2024-09-06","current":-4.171688,"twenty":-23.2407,"median":-8.189602,"eighty":-4.480996,"marketCap":316697893},{"date":"2024-09-13","current":-4.092119,"twenty":-22.946288,"median":-7.78069,"eighty":-4.395806,"marketCap":310657334},{"date":"2024-09-20","current":-3.631756,"twenty":-20.733738,"median":-7.624508,"eighty":-4.308092,"marketCap":275708384},{"date":"2024-09-27","current":-2.97247,"twenty":-18.634621,"median":-7.456968,"eighty":-4.211473,"marketCap":225658035},{"date":"2024-10-04","current":-2.63146,"twenty":-17.741488,"median":-7.394495,"eighty":-4.171688,"marketCap":199769924},{"date":"2024-10-11","current":-2.983837,"twenty":-17.707293,"median":-7.116207,"eighty":-4.052335,"marketCap":226520973},{"date":"2024-10-18","current":-3.205494,"twenty":-17.620069,"median":-6.641982,"eighty":-3.978375,"marketCap":243348245},{"date":"2024-10-25","current":-2.909952,"twenty":-17.56293,"median":-5.951944,"eighty":-3.964176,"marketCap":220911882},{"date":"2024-11-01","current":-2.779231,"twenty":-17.2201,"median":-5.608344,"eighty":-3.873307,"marketCap":210988106},{"date":"2024-11-08","current":-3.006571,"twenty":-17.062969,"median":-5.514635,"eighty":-3.751109,"marketCap":228246847},{"date":"2024-11-15","current":-1.697135,"twenty":-16.627288,"median":-5.392529,"eighty":-3.322005,"marketCap":187796512},{"date":"2024-11-22","current":-1.712741,"twenty":-16.355881,"median":-5.065967,"eighty":-3.177076,"marketCap":189523376},{"date":"2024-11-29","current":-2.251143,"twenty":-16.350167,"median":-4.969419,"eighty":-3.054313,"marketCap":249100201},{"date":"2024-12-06","current":-1.775165,"twenty":-16.285886,"median":-4.789428,"eighty":-3.003161,"marketCap":196430834},{"date":"2024-12-13","current":-1.724446,"twenty":-16.121613,"median":-4.674093,"eighty":-2.977017,"marketCap":190818525},{"date":"2024-12-20","current":-1.560584,"twenty":-16.033048,"median":-4.573541,"eighty":-2.950873,"marketCap":172686448},{"date":"2024-12-27","current":-1.556683,"twenty":-15.964482,"median":-4.562178,"eighty":-2.903132,"marketCap":172254731},{"date":"2025-01-03","current":-1.599599,"twenty":-15.904487,"median":-4.538274,"eighty":-2.797418,"marketCap":177003609},{"date":"2025-01-10","current":-1.346004,"twenty":-15.82735,"median":-4.480996,"eighty":-2.693979,"marketCap":148942061},{"date":"2025-01-17","current":-1.299186,"twenty":-15.443094,"median":-4.435561,"eighty":-2.615547,"marketCap":143761467},{"date":"2025-01-24","current":-1.404526,"twenty":-14.591731,"median":-4.395806,"eighty":-2.532048,"marketCap":155417803},{"date":"2025-01-31","current":-1.264073,"twenty":-13.927497,"median":-4.353211,"eighty":-2.095084,"marketCap":139876022},{"date":"2025-02-07","current":-1.170438,"twenty":-13.706085,"median":-4.259502,"eighty":-1.931223,"marketCap":129514836},{"date":"2025-02-14","current":-1.182143,"twenty":-13.577524,"median":-4.21845,"eighty":-1.814179,"marketCap":130809984},{"date":"2025-02-21","current":-1.084606,"twenty":-13.114702,"median":-4.187318,"eighty":-1.73693,"marketCap":120017081},{"date":"2025-02-28","current":-1.108015,"twenty":-12.719019,"median":-4.171688,"eighty":-1.688552,"marketCap":122607378},{"date":"2025-03-07","current":-1.01438,"twenty":-12.020501,"median":-4.104819,"eighty":-1.598038,"marketCap":112246191},{"date":"2025-03-14","current":-0.975365,"twenty":-11.480543,"median":-3.998252,"eighty":-1.555903,"marketCap":107929030},{"date":"2025-03-21","current":-0.928548,"twenty":-11.116285,"median":-3.978412,"eighty":-1.525471,"marketCap":102748436},{"date":"2025-03-28","current":-0.678003,"twenty":-10.923443,"median":-3.972766,"eighty":-1.481775,"marketCap":86429836},{"date":"2025-04-04","current":-0.671223,"twenty":-10.829164,"median":-3.959945,"eighty":-1.403746,"marketCap":85565537},{"date":"2025-04-11","current":-0.698343,"twenty":-10.750599,"median":-3.915931,"eighty":-1.33508,"marketCap":89022731},{"date":"2025-04-17","current":-0.630601,"twenty":-10.726315,"median":-3.836362,"eighty":-1.299186,"marketCap":80387103},{"date":"2025-04-25","current":-0.711969,"twenty":-10.557757,"median":-3.76816,"eighty":-1.283581,"marketCap":90759633},{"date":"2025-05-02","current":-0.772995,"twenty":-10.436338,"median":-3.711325,"eighty":-1.243785,"marketCap":98539030},{"date":"2025-05-09","current":-0.715359,"twenty":-10.170644,"median":-3.266591,"eighty":-1.184484,"marketCap":91191822},{"date":"2025-05-16","current":-0.68951,"twenty":-9.982087,"median":-3.188443,"eighty":-1.152492,"marketCap":100267785},{"date":"2025-05-23","current":-0.73409,"twenty":-9.837812,"median":-3.142975,"eighty":-1.119719,"marketCap":106750616},{"date":"2025-05-30","current":-0.781642,"twenty":-9.466412,"median":-3.049198,"eighty":-1.09553,"marketCap":113665635},{"date":"2025-06-06","current":-0.873775,"twenty":-9.030538,"median":-3.023622,"eighty":-1.030766,"marketCap":127063486},{"date":"2025-06-13","current":-1.02832,"twenty":-8.929052,"median":-2.986679,"eighty":-1.018767,"marketCap":149537300},{"date":"2025-06-20","current":-0.864859,"twenty":-8.793883,"median":-2.980995,"eighty":-1.008108,"marketCap":125766920},{"date":"2025-06-27","current":-1.031292,"twenty":-8.738225,"median":-2.966787,"eighty":-0.98785,"marketCap":149969489},{"date":"2025-07-03","current":-0.835139,"twenty":-8.660987,"median":-2.95542,"eighty":-0.975365,"marketCap":121445033},{"date":"2025-07-11","current":-1.061012,"twenty":-8.20664,"median":-2.912794,"eighty":-0.974824,"marketCap":154291376},{"date":"2025-07-18","current":-1.209614,"twenty":-8.200961,"median":-2.836066,"eighty":-0.975365,"marketCap":175900813},{"date":"2025-07-25","current":-1.260138,"twenty":-8.178243,"median":-2.779231,"eighty":-0.975365,"marketCap":183248021},{"date":"2025-08-01","current":-1.061012,"twenty":-7.803407,"median":-2.688295,"eighty":-0.975365,"marketCap":154291376},{"date":"2025-08-08","current":-0.98374,"twenty":-7.78069,"median":-2.625776,"eighty":-0.98374,"marketCap":143054469},{"date":"2025-08-15","current":-0.964666,"twenty":-7.68982,"median":-2.585992,"eighty":-0.974824,"marketCap":153089661},{"date":"2025-08-22","current":-0.975567,"twenty":-7.678462,"median":-2.530603,"eighty":-0.962936,"marketCap":154819487},{"date":"2025-08-29","current":-1.008267,"twenty":-7.570554,"median":-2.118493,"eighty":-0.964666,"marketCap":160008967},{"date":"2025-09-05","current":-0.989192,"twenty":-7.52512,"median":-1.993646,"eighty":-0.964666,"marketCap":156981771},{"date":"2025-09-12","current":-1.130894,"twenty":-7.468327,"median":-1.952681,"eighty":-0.972792,"marketCap":179469518},{"date":"2025-09-19","current":-1.365248,"twenty":-7.429707,"median":-1.872701,"eighty":-0.975257,"marketCap":216660791},{"date":"2025-09-26","current":-1.730404,"twenty":-7.422892,"median":-1.802474,"eighty":-0.975365,"marketCap":274609985},{"date":"2025-10-03","current":-1.656828,"twenty":-7.377457,"median":-1.775165,"eighty":-0.975365,"marketCap":262933655},{"date":"2025-10-10","current":-1.923883,"twenty":-7.30249,"median":-1.765048,"eighty":-0.975527,"marketCap":305314409},{"date":"2025-10-17","current":-1.910257,"twenty":-7.150283,"median":-1.79077,"eighty":-0.977747,"marketCap":303152125},{"date":"2025-10-24","current":-1.74403,"twenty":-7.070773,"median":-1.806706,"eighty":-0.98265,"marketCap":276772268},{"date":"2025-10-31","current":-1.839406,"twenty":-7.009436,"median":-1.817606,"eighty":-0.98374,"marketCap":291908252},{"date":"2025-11-07","current":-1.932058,"twenty":-6.429007,"median":-1.834596,"eighty":-0.986404,"marketCap":306611779},{"date":"2025-11-14","current":-1.76583,"twenty":-6.028046,"median":-1.829785,"eighty":-0.98707,"marketCap":280231922},{"date":"2025-11-21","current":-2.023973,"twenty":-5.954216,"median":-1.856881,"eighty":-0.988768,"marketCap":325843504},{"date":"2025-11-28","current":-2.086542,"twenty":-5.791787,"median":-1.873766,"eighty":-0.989487,"marketCap":335916623},{"date":"2025-12-05","current":-2.132789,"twenty":-5.650939,"median":-1.874832,"eighty":-0.990456,"marketCap":343361972},{"date":"2025-12-12","current":-2.27425,"twenty":-5.604368,"median":-1.895008,"eighty":-0.995653,"marketCap":366135981},{"date":"2025-12-19","current":-1.904276,"twenty":-5.571428,"median":-1.899357,"eighty":-1.000453,"marketCap":306573190},{"date":"2025-12-26","current":-2.445634,"twenty":-5.541896,"median":-1.907532,"eighty":-1.00316,"marketCap":393727568},{"date":"2026-01-02","current":-3.335677,"twenty":-5.503276,"median":-1.923883,"eighty":-1.005937,"marketCap":537017328},{"date":"2026-01-09","current":-2.998561,"twenty":-5.448754,"median":-1.93164,"eighty":-1.007666,"marketCap":482744300},{"date":"2026-01-16","current":-3.094373,"twenty":-5.404456,"median":-1.947802,"eighty":-1.008709,"marketCap":498169266},{"date":"2026-01-23","current":-3.729571,"twenty":-5.372651,"median":-1.953858,"eighty":-1.010478,"marketCap":600431076},{"date":"2026-01-30","current":-2.913395,"twenty":-5.344255,"median":-1.965361,"eighty":-1.010992,"marketCap":469033219},{"date":"2026-02-06","current":-2.579827,"twenty":-5.065967,"median":-1.978384,"eighty":-1.01346,"marketCap":415331486},{"date":"2026-02-13","current":-2.611764,"twenty":-5.054609,"median":-2.003915,"eighty":-1.013717,"marketCap":420473142},{"date":"2026-02-20","current":-2.87436,"twenty":-4.986457,"median":-2.025703,"eighty":-1.014247,"marketCap":462748974},{"date":"2026-02-27","current":-2.881457,"twenty":-4.928528,"median":-2.043785,"eighty":-1.01438,"marketCap":463891564},{"date":"2026-03-06","current":-2.977269,"twenty":-4.827435,"median":-2.086542,"eighty":-1.020777,"marketCap":479316530},{"date":"2026-03-13","current":-3.112116,"twenty":-4.780255,"median":-2.118493,"eighty":-1.024754,"marketCap":501025741},{"date":"2026-03-20","current":-3.030498,"twenty":-4.769593,"median":-2.129165,"eighty":-1.025937,"marketCap":487885955},{"date":"2026-03-27","current":-3.012142,"twenty":-4.692966,"median":-2.151832,"eighty":-1.027873,"marketCap":484930840},{"date":"2026-04-02","current":-3.286851,"twenty":-4.628408,"median":-2.225282,"eighty":-1.029368,"marketCap":530192007},{"date":"2026-04-10","current":-3.590425,"twenty":-4.584311,"median":-2.250455,"eighty":-1.030802,"marketCap":579160710},{"date":"2026-04-17","current":-3.571686,"twenty":-4.573206,"median":-2.388506,"eighty":-1.03519,"marketCap":576137951},{"date":"2026-04-24","current":-3.358479,"twenty":-4.567056,"median":-2.487395,"eighty":-1.037789,"marketCap":541746122},{"date":"2026-05-01","current":-3.302191,"twenty":-4.561844,"median":-2.543569,"eighty":-1.038061,"marketCap":532666578},{"date":"2026-05-08","current":-3.489816,"twenty":-4.559102,"median":-2.569768,"eighty":-1.044783,"marketCap":562931724},{"date":"2026-05-15","current":-4.15662,"twenty":-4.534296,"median":-2.581654,"eighty":-1.052413,"marketCap":650095346},{"date":"2026-05-22","current":-3.444499,"twenty":-4.49595,"median":-2.613087,"eighty":-1.058444,"marketCap":538719607},{"date":"2026-05-29","current":-3.347743,"twenty":-4.480996,"median":-2.625776,"eighty":-1.061012,"marketCap":523587034},{"date":"2026-06-05","current":-3.076828,"twenty":-4.471909,"median":-2.688295,"eighty":-1.061714,"marketCap":481215829},{"date":"2026-06-12","current":-3.045866,"twenty":-4.449191,"median":-2.698705,"eighty":-1.063858,"marketCap":476373405},{"date":"2026-06-18","current":-3.11166,"twenty":-4.431665,"median":-2.713919,"eighty":-1.066038,"marketCap":486663555},{"date":"2026-06-26","current":-3.187473,"twenty":-4.412024,"median":-2.725319,"eighty":-1.06856,"marketCap":498520738},{"date":"2026-07-02","current":-3.280765,"twenty":-4.395806,"median":-2.779231,"eighty":-1.069929,"marketCap":513111589},{"date":"2026-07-10","current":-3.813306,"twenty":-4.390126,"median":-2.789213,"eighty":-1.073668,"marketCap":596401029},{"date":"2026-07-17","current":-2.892048,"twenty":-4.36173,"median":-2.806937,"eighty":-1.084606,"marketCap":452316377},{"date":"2026-07-24","current":-2.833741,"twenty":-4.344692,"median":-2.815944,"eighty":-1.092409,"marketCap":443197095},{"date":"2026-07-31","current":-2.911484,"twenty":-4.315412,"median":-2.817583,"eighty":-1.094857,"marketCap":455356137},{"date":"2026-08-07","current":-3.01255,"twenty":-4.26922,"median":-2.824699,"eighty":-1.099263,"marketCap":471162893},{"date":"2026-08-14","current":-3.273726,"twenty":-4.239266,"median":-2.836847,"eighty":-1.106454,"marketCap":499695027},{"date":"2026-08-21","current":-3.293984,"twenty":-4.227182,"median":-2.842423,"eighty":-1.108015,"marketCap":502787199},{"date":"2026-08-28","current":-3.500618,"twenty":-4.222326,"median":-2.869037,"eighty":-1.115418,"marketCap":534327356},{"date":"2026-09-04","current":-3.383121,"twenty":-4.213489,"median":-2.87436,"eighty":-1.117439,"marketCap":516392757},{"date":"2026-09-11","current":-2.977956,"twenty":-4.201242,"median":-2.881457,"eighty":-1.123506,"marketCap":454549313},{"date":"2026-09-18","current":-2.852356,"twenty":-4.185897,"median":-2.878979,"eighty":-1.129545,"marketCap":435377845},{"date":"2026-09-25","current":-2.832097,"twenty":-4.18008,"median":-2.881457,"eighty":-1.131212,"marketCap":432285673},{"date":"2026-09-29","current":-2.763219,"twenty":-4.179991,"median":-2.8765,"eighty":-1.131424,"marketCap":421772288}],"updateTime":1790832336392},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669945074","title":"US Stocks on the MOVE-Charles River, Oracle, TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2669945074","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669945074?lang=en_us&edition=fundamental","pubTime":"2026-09-24 23:44","pubTimestamp":1790264673,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Charles River, Oracle, TD SynnexSeptember 24 (Reuters)-Wall Street's main indexes dropped on Thursday as uncertainty over prospects for a resolution to the Middle East confl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL6N45G10O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARES","VSNT","ERX","CTEC","SFIX","IXC","PWR","VOYG","MGM","LLY","LU","XXII","WHLR","ACAD","CRL","GRML","OXY","VLO","ROL","DBX","IEF","ATYR","NEM","PMAX","AU","PIPR","TLT","DK","CVX","VKTX","OWL","APA","DAVA","ORCL","P","SRZN","XOM","KYTX","CG","AGNG","IHE","RSKD","SNX","GETY","CORD","IXJ","DRI","TWST","CRWV","FSLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669049359","title":"Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669049359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669049359?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:50","pubTimestamp":1790254216,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aethlon Medical (AEMD) and Kyverna Therapeutics, I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aethlon-medical-aemd-and-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aethlon-medical-aemd-and-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","KYTX","LU0128526141.USD","LU0029874061.USD","XLV","BK4585","BK4139","BK4588","BK4568","AEMD","BK4581","XBI","BK4583","BK4082","HCSG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669446047","title":"U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants","url":"https://stock-news.laohu8.com/highlight/detail?id=2669446047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669446047?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:12","pubTimestamp":1790251979,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Everpure, Dropbox, Darden RestaurantsSeptember 24 (Reuters)-Wall Street futures dropped on Thursday as the Middle East conflict remained far from a resolution, while inves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL6N45G0Q9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","LU2394011477.USD","LU0154245756.USD","TLT","LU0323239441.USD","LU1815336760.USD","BK4129","TSYW","LU0154245673.USD","BK4023","TLTX","IEI","LU2087625088.SGD","BK4581","ARKG","BK4209","ACAD","IEF","LU0353189680.USD","TLH","TBJL","BWZ","LU2065170008.USD","TFJL","BK4585","P","ISHG","LU1093756325.SGD","BK4139","BK4598","TLTI","IDNA","BK4588","FLGV","BK4504","LU0444971666.USD","BK4528","GNOM","LU2065171311.SGD","GRML","THNR","LU1804176565.USD","SG9999001440.SGD","KYTX","LU1261432733.SGD","ZAP","LU1642822529.SGD","PWR","SGOV","LU1571399168.USD","PUL","VKTX","POW","GRID","BK4532","BBLB","SFIX","LU1917777945.USD","BK4534","BBIB","DBX","LU2023250843.SGD","BK4122","LU2065171402.SGD","HWAY","LU0323240290.USD","BBSB","BWX","DRI","BK4551","LU2023250504.SGD","BK4170","LU2265009873.SGD","SHY","ODDZ","BK4094","BK4599","BK4567","LU0957808578.USD","JOUL","LU2065169927.USD","WDNA","TWST","SHV","BK4561","POWR","LU0353189763.USD","OZEM","LU1093756168.USD","IGOV","LU1974910355.USD","TLTW","LU2237438978.USD","MGM","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462005","title":"Kyverna Rises as Cell Therapy Shows Durable Benefit in Rare Nerve Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462005","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669462005?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:21","pubTimestamp":1790248895,"startTime":"0","endTime":"0","summary":"BUZZ-Kyverna rises as cell therapy shows durable benefit in rare nerve disease** Shares of biotech firm Kyverna TherapeuticsKYTX.Orise 6.1% to $7.50 premarket** Co says its experimental cell therapy, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G0W0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669211461","title":"Swarmer’s miv-cel shows positive results in stiff person syndrome and gMG","url":"https://stock-news.laohu8.com/highlight/detail?id=2669211461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669211461?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:10","pubTimestamp":1790244629,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics (KYTX) announced positive one-year topline data from KYSA-8, its registrational trial of miv-cel – mivocabtagene autoleucel, K...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/swarmers-miv-cel-shows-positive-results-in-stiff-person-syndrome-and-gmg-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/swarmers-miv-cel-shows-positive-results-in-stiff-person-syndrome-and-gmg-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4187","KYTX","SWMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461801","title":"Kyverna Reports Positive 1-Year KYSA-8 Trial Data for Miv-Cel in Stiff Person Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461801","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461801?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:01","pubTimestamp":1790244066,"startTime":"0","endTime":"0","summary":"Kyverna reports positive 1-year KYSA-8 trial data for miv-cel in stiff person syndromeKyverna reported positive one-year durability data for miv-cel in stiff person syndrome from its KYSA-8 registrati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL7lVzYY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4139","LU0314104364.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","SG9999014021.USD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014005.SGD","BK4588","LU2095319765.USD","IE00BQXX3F31.USD","BCDF","BK4585","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669469047","title":"Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-Cel in Stiff Person Syndrome and Generalized Myasthenia Gravis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669469047","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669469047?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:00","pubTimestamp":1790244001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA7656BS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461353","title":"Kyverna Therapeutics, - Phase 3 Kysa-6 Trial Enrollment Expected to be Completed in Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461353","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461353?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:00","pubTimestamp":1790244001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA7656BS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461352","title":"Kyverna Therapeutics, - Miv-Cel Well-Tolerated in Gmg Trial with no High-Grade Crs, Icans, or Iec-Hs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461352?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:00","pubTimestamp":1790244001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA7656BS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849513","title":"Kyverna Therapeutics to Present at Wells Fargo Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849513","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849513?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:07","pubTimestamp":1788379633,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics to present at Wells Fargo Healthcare Conference fireside chatKyverna will present at the 2026 Wells Fargo Healthcare Conference on Sept. 9, 2026 at 4:30 p.m. ET.Management will al","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL2mys1w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1988902786.USD","LU2357305700.SGD","SG9999014013.SGD","LU1074936037.SGD","LU1244550494.USD","LU1791710400.SGD","LU0267386448.USD","IAI","LU2089283258.USD","IE00B775SV38.USD","LU0390134368.USD","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BN0W2V16.EUR","LU1732800096.USD","LU2264538146.SGD","LU0106831901.USD","LU1720051108.HKD","LU1244550221.USD","LU1244550577.SGD","LU1720051017.SGD","LU2089284900.SGD","LU1668664300.SGD","BK4127","NDAQ","LU0225283273.USD","IE00BZ1G4Q59.USD","LU0882574139.USD","LU0314104364.USD","LU1162221912.USD","KBWB","LU0106261372.USD","LU0234570918.USD","LU1064131342.USD","IE00BKPKM429.USD","LU2271345857.HKD","KYTX","BCDF","LU2210150020.SGD","SG9999014039.USD","BK4139","LU2487616109.SGD","IE00B64PRP62.GBP","LU0158827781.USD","LU0557290698.USD","BK4534","BK4588","BK4581","IE00B3S45H60.SGD","LU0210528500.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658979618","title":"Kyverna Therapeutics: Buy Rating Reiterated as Pipeline Progress and Strong Financial Runway Support Unchanged $25 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2658979618","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658979618?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:35","pubTimestamp":1786530946,"startTime":"0","endTime":"0","summary":"Analyst Mitchell Kapoor of H.C. Wainwright reiterated a Buy rating on Kyverna Therapeutics, Inc., retaining the price target of $25.00. Mitchell Ka...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kyverna-therapeutics-buy-rating-reiterated-as-pipeline-progress-and-strong-financial-runway-support-unchanged-25-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kyverna-therapeutics-buy-rating-reiterated-as-pipeline-progress-and-strong-financial-runway-support-unchanged-25-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYTX","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978453","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF), Kyverna Therapeutics, Inc. (KYTX) and Pliant Therapeutics (PLRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978453","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658978453?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:50","pubTimestamp":1786524608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tecan Group AG (TCHBF), Kyverna Therapeutics, Inc. (KYTX) and Pli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-tecan-group-ag-othertchbf-kyverna-therapeutics-inc-kytx-and-pliant-therapeutics-plrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-tecan-group-ag-othertchbf-kyverna-therapeutics-inc-kytx-and-pliant-therapeutics-plrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","SLJY","PLRX","XLV","XBI","AG","BK4137","KYTX","SLVX","BK4585","BK4139","BK4007","BK4210","LU0029874061.USD","SLVR","TCHBF","SILJ","BK4588","BK4121","BK4581","LU0128526141.USD","TCGGY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945596","title":"Kyverna Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945596","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945596?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:41","pubTimestamp":1786480899,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryKyverna Therapeutics, Inc.KYTX.OQreported a quarterly adjusted loss of 63 cents per share for the quarter end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N448245:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658436529","title":"Kyverna Therapeutics Q2 EPS $(0.63) Beats $(0.68) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658436529","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658436529?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:18","pubTimestamp":1786479525,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics (NASDAQ:KYTX) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.68) by 7.35 percent. This is a 35.05 percent increase over losses of $(0.97) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61127199/kyverna-therapeutics-q2-eps-0-63-beats-0-68-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Kyverna Therapeutics Q2 EPS $(0.63) Beats $(0.68) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943139","title":"Kyverna Therapeutics reports Q2 EPS (63c), consensus (68c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943139","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943139?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:15","pubTimestamp":1786479341,"startTime":"0","endTime":"0","summary":"“Kyverna continues to advance our rolling BLA submission for stiff person syndrome, progress commercial launch readiness activities and accelerate ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-reports-q2-eps-63c-consensus-68c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-reports-q2-eps-63c-consensus-68c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658012948","title":"Kyverna Therapeutics Rilis Presentasi Investor Soal Terapi CAR-T Miv-Cel Untuk Penyakit Autoimun Neurologis","url":"https://stock-news.laohu8.com/highlight/detail?id=2658012948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658012948?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:10","pubTimestamp":1786479009,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics rilis presentasi investor soal terapi CAR-T miv-cel untuk penyakit autoimun neurologisKyverna Therapeutics Inc. menegaskan fokus pada penyakit autoimun neurologis, dipimpin mivoca","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL2Xq4sp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658394868","title":"Kyverna Therapeutics Rugi Bersih Q2 FY26 Menyempit Jadi USD 38,32 Juta","url":"https://stock-news.laohu8.com/highlight/detail?id=2658394868","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658394868?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:04","pubTimestamp":1786478674,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics rugi bersih Q2 FY26 menyempit jadi USD 38,32 jutaKyverna Therapeutics membukukan rugi bersih 2Q 2026 sebesar USD 38,32 juta, menyempit dari USD 42,08 juta setahun sebelumnya.Rugi ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDLbmB9qD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","BCDF","IE00BGHQF748.EUR","NDAQ","IE00BN0W2W23.USD","BK4588","LU0314104364.USD","BK4585","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","KYTX","BK4112","IE00B64PRP62.GBP","BK4139","LU2210149790.SGD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945653","title":"Kyverna Therapeutics - on Track to Complete Rolling Bla Submission for Miv-Cel in SPS in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945653?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:02","pubTimestamp":1786478520,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA81FJC8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945628","title":"Kyverna Therapeutics - Kysa-8 12-Month Topline Data Expected in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945628","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945628?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:02","pubTimestamp":1786478520,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA81FJC8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948500","title":"Press Release: Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948500","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948500?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:02","pubTimestamp":1786478520,"startTime":"0","endTime":"0","summary":"-- Kyverna has initiated its rolling BLA, submitted the Chemistry,Manufacturing and Controls  module and is on track to. complete its submission in the fourth quarter of 2026.-- The Company plans to seek priority review, under the Regenerative. -- Kyverna continues to advance activities to enable a successful. rare disease launch in SPS upon approval. These efforts include. hiring key commercial leadership roles, commercial site activation,a commercial supply agreement, payer and patient advocacy. -- The Company plans to report 12-month topline data from KYSA-8 in. -- Enrollment Ongoing in KYSA-6 Registrational Trial for gMG:. -- Kyverna continues to advance its Phase 3 gMG trial and expects to. complete enrollment by mid-2027. The Company anticipates sharing. longer-term follow-up Phase 2 topline data in Q3 2026.-- Advancing Progressive Multiple Sclerosis  Strategy with RMAT. Designation Granted for Miv-cel for Treatment of No","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRGS","IE00B1BXHZ80.USD","LU0149725797.USD","BK4006","LU2746668974.SGD","LU0170899867.USD","LU0882574139.USD","LU2746668461.USD","CMC","IE00BKVL7J92.USD","LU2065732104.USD","KYTX","IE00BHPRN162.USD","BK4139","LU2237443382.USD","LU2237443895.HKD","LU2237443549.SGD","LU0267386448.USD","BK4097","IE00BZ1G4Q59.USD","LU1363072403.SGD","LU2237443978.SGD","IE00BFXG1179.USD","LU2237443622.USD","LU0971096721.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":90,"code":"91000000","status":"200"}]}}